• 제목/요약/키워드: Bariatric

검색결과 27건 처리시간 0.02초

한약추출물을 함유한 식사대용식이가 체중감량과 초저열량식이의 부작용에 미치는 영향 (The effects of Very Low Calorie Diet using meal replacements that contain Herbal extracts on weight reduction and health promotion)

  • 최승;김지영;장유경;김상연;박미현;홍성길;황성주;최형석
    • 한방비만학회지
    • /
    • 제4권1호
    • /
    • pp.81-94
    • /
    • 2004
  • Background: The VLCD that supplies only 400-800kcal meal per day has a lot of problems and can severely harm the health. Certain herbs are known to the side-effects such as weakness, skin dehydration, and dizziness. If VLCD with meal-replacement containing these hearbs can effectively minimize the side-effects, it make weight management easier and reduce any possible danger the health. Objectives: This prospective, double-blinded study is intended to compare the severity of symptoms induced by VLCD and weight loss between the case group supplied with meal-replacement herbal extracts(n=29) and controlled group supplied with meal-replacement not containing herbal extracts(n=29). This was with 52 volunteers for 4 weeks. The measurements of this experiment were as follows: symptoms caused by patients' subjective judgments, the result of blood test illustratingerol level, total protein etc., and changes in overall weight, fat mass and lean body mass. Result: we concluded that there are no significant differences in weight change between case group and controlled group, and that the total protein at the end of trial was significantly higher in case group than in controlled group, and triglyceride level at the end of trial was lower in case group than in controlled group. As expected, the side-effects such as hair loss and dehydration in skin are also lessin case group than in controlled group.

  • PDF

고도비만환자에서 베리아트릭 수술 (Bariatric Surgery) 후 영양교육이 체중감량에 미치는 효과 (Weight loss effects of Bariatric Surgery after nutrition education in extremely obese patients)

  • 정은하;이홍찬;임정은
    • Journal of Nutrition and Health
    • /
    • 제48권1호
    • /
    • pp.30-45
    • /
    • 2015
  • 본 연구는 베리아트릭 수술 중 위 밴드 수술을 시행한 고도비만 환자의 특성을 밝히고, 수술 후 영양교육을 받은 횟수의 차이가 체중감량에 미치는 영향을 평가하기 위해 시행되었다. 위 밴드 수술을 시행한 환자 중 수술 후 15개월이 경과한 고도비만 환자의 의무기록을 이용한 후향적 조사이다. 총 60명을 연구 대상으로 선정하였으며, 전체 연구 대상자들이 개별적으로 이루어진 영양교육을 받은 횟수의 평균을 기준으로 평균 보다 작은 경우 소교육군으로, 평균보다 높은 경우 다교육군으로 분류하여 조사하였다. 본 연구의 결과를 요약하면 다음과 같다. 첫째, 본 연구의 연구 대상자는 총 60명으로 소교육군은 29명, 다교육군은 31명으로, 위 밴드 수술 전에 조사된 성별, 연령, 신장, 체중, BMI 모두 두 그룹간의 유의적인 차이가 없었다. 혈압과 맥박은 이완기 혈압과 맥박은 두 그룹간의 유의적인 차이가 나타나지 않은 반면 수축기 혈압에서 다교육군이 소교육군보다 유의적으로 높게 나타났다. 둘째, 위 밴드 수술 전에 조사 된 연구 대상자들이 가지고 있는 건강 관련 생활 습관은 음주, 민간요법, 흡연 순으로 나타났다. 음주, 흡연에서는 두 그룹간의 유의적인 차이가 나타나지 않았으나 민간요법 사용 여부에서 다교육군이 유의적으로 높게 나타났다. 셋째, 연구 대상자의 위 밴드 수술 전에 조사된 비만관련 합병증과 보유증상은 등, 허리, 무릎 통증, 코골이, 생리불순, 위-식도역류질환, 수면문제, 고혈압, 수면무호흡증, 당뇨병, 고지혈증 등의 순으로 나타났다. 우울증과 코골이에서 두 그룹간의 유의적인 차이가 나타났다. 우울증의 경우 다교육군이 유의적으로 높았으며, 코골이의 경우 소교육군이 유의적으로 높게 나타났다. 넷째, 연구 대상자들의 식습관 중 속식을 하는 경우가 가장 많았으며, 그 다음으로 과식, 불규칙한 식사 시간, 스트레스성 식사, 잦은 간식 섭취, Junk Food 섭취, 야식, 단 음식 섭취 순으로 나타났다. 식습관은 두 그룹간의 유의적인 차이는 나타나지 않았다. 다섯째, 대부분의 연구 대상자가 비수술적 요법을 시행한 경험이 있으며, 약물요법을 가장 많이 시행한 경험이 있다고 답하였다. 그 다음으로 운동요법, 식사요법, 행동수정요법 순으로 나타났다. 연구 대상자의 위 밴드 수술 전에 조사된 비수술적 요법 시행 여부는 두 그룹간의 유의적인 차이는 나타나지 않았다. 약물요법을 소교육군은 4가지 이상 시행한 경우가 가장 많았고, 다교육군은 1가지, 3가지를 시행한 경우가 가장 많았다. 운동요법을 소교육군은 유산소 운동만 한 경우가 가장 많았고, 다교육군은 유산소 운동과 근력 운동을 병행한 경우가 가장 많았다. 식사요법으로 가장 많이 사용한 방법은 두 그룹 모두 보조식품을 이용하는 것으로 나타났다. 여섯째, 신체조성 측정 결과 수술 후 6개월까지는 체지방, 체중이 급격히 감소하였고, 그 후에는 완만하게 감소하였다. 체지방과 체중은 수술 후 15개월 차에 영양교육을 더 많이 받은 다교육군이 소교육군 보다 유의적으로 낮게 나타났다. 일곱째, 수술 전과 수술 후 기간 경과에 따른 비만 지표 체중과 체지방의 감소와 비슷한 변화 양상을 나타내었다. BMI와 비만도는 수술 후 15개월 차에 소교육군에 비해 다교육군이 유의적으로 낮게 나타났다. 교육 횟수가 증가 할수록 수술 전에 비해 수술 후 15개월에 BMI 감소 정도가 증가하는 것으로 나타났다. 여덟째, 연구 대상자의 위 밴드 수술 전과 수술 후 6개월 차의 생화학적 지표를 조사한 결과 대부분이 정상 범위에 있는 것으로 나타났다. ALT, 중성지방, 총 콜레스테롤이 수술 전 정상범위보다 높게 나타났으나 수술 후 6개월 차에 정상범위 수준으로 감소하였다. 간 기능 지표를 나타내는 AST와 ALT는 수술 전에 비해 수술 후 6개월 차에 두 그룹 모두 유의적으로 감소하였다. 당화혈색소 역시 두 그룹 모두 수술 전에 비해 수술 후 6개월 차에 유의적으로 감소하였다. 중성지방은 수술 전에 두 그룹 모두 정상범위 이상이었으나 수술 후 6개월 차에 정상범위 수준으로 감소되었고 수술 전에 비해 수술 후 6개월 차에 유의적으로 감소하였다. 본 연구를 통해 고도비만환자들이 베리아트릭 수술 시행 전에 가지고 있던 인류 통계학적 특성, 식습관, 비만 관련 합병증과 보유 증상, 비수술적 요법의 시행 여부 등을 알 수 있었다. 또한 이를 기초 자료로 한 베리아트릭 수술 후 장기적인 영양교육을 실시하는 것이 체중과 체지방량의 감소에 영향을 미치는 것을 확인하였다. 이는 고도비만 환자의 베리아트릭 수술로 인한 체중과 체지방의 감소 효과를 지속적으로 유지하기 위해서는 장기적인 영양교육이 필요함을 보여준다. 향후 연구 대상자의 특징을 고려하여 개별적인 영양교육을 통해 비만 수술 후 전향적인 중재를 시행하여 혈압, 비만 관련 합병증과 보유 증상, 식습관 및 건강 관련 생활습관의 변화에 대한 조사와 영양교육 방법에 대한 실제적 효과를 판정하는 연구가 필요한 것으로 사료된다.

양성(養性)치료가 여성들의 체중감소와 자존감, 자기통제에 미치는 영향 (The effect of 'Oriental medical cognitive therapy(Yangsung program) for obesity' on self esteem, self control and weight of women)

  • 최승;송원영;이영진;최형석
    • 한방비만학회지
    • /
    • 제4권1호
    • /
    • pp.161-183
    • /
    • 2004
  • Context : Oriental medicine deals with mind cardinally and effectiveness of CBT on weight control is well-known. but there is no well-structured psychotherapy for weight control like CBT in Oriental medicine so far. Therefore It is necessary to develop new cognitive program based on the theory of Oriental medical. Objective: This study examined whether Yangsung program based on new cognitive weight regulation model is effective on weight loss, self esteem and self control. Design and setting: 44 women were assigned randomly to 2 groups; experimental group(n=24) and control group(n=10). experimental group had 11 sessions consisted of cognitive therapy, meditation, general diet and exercise education. Control group had personal interview with general diet and exercise education and ear acupuncture once a week for two months. All subjects were weighed and evaluated with Rosenberg self esteem scale, and three factor eating questionnaires at the beginning of the program and at the end of the program. Result: Experimental group reported significant changes of weight, self esteem, restraint eating, disinhibition and hunger(p<0.01). Compared with control group, more significant(p<0.05) Weight reduction and self-esteem enhancement were reported in experimental group than control group. There is no significant difference between two groups in changes of restraint eating, disinhibition and hunger.

  • PDF

Abdominal Hypertension after Abdominal Plication in Postbariatric Patients: The Consequence in the Postoperative Recovery

  • Martin Morales-Olivera;Erik Hanson-Viana;Armando Rodriguez-Segura;Marco A. Rendon-Medina
    • Archives of Plastic Surgery
    • /
    • 제50권6호
    • /
    • pp.535-540
    • /
    • 2023
  • Background Abdominoplasty with abdominal plication increases intra-abdominal pressure (IAP) and has been previously associated with limited diaphragmatic excursion and respiratory dysfunctions. Many factors found in abdominoplasties and among postbariatric patients predispose them to a higher occurrence. This study aims to evaluate the impact of abdominal plication among postbariatric patients, assess whether the plication increases their IAP, and analyze how these IAP correlate to their postoperative outcome. Methods This prospective study was performed on all patients who underwent circumferential Fleur-De-Lis abdominoplasty. For this intended study, the IAP was measured by an intravesical minimally invasive approach in three stages: after the initiation of general anesthesia, after a 10-cm abdominal wall plication and skin closure, and 24 hours after the procedure. Results We included 46 patients, of which 41 were female and 5 were male. Before the bariatric procedure, these patients had an average maximum weight of 121.4 kg and an average maximum body mass index of 45.78 kg/m2; 7 were grade I obese patients, 10 were grade II, and 29 were grade III. Only three patients were operated on with a gastric sleeve and 43 with gastric bypass. We presented six patients with transitory intra-abdominal hypertension in the first 24 hours, all of them from the grade I obesity group, the highest presented was 14.3 mm Hg. We presented 15% (7/46) of complication rates, which were only four seroma and five dehiscence; two patients presented both seroma and wound dehiscence. Conclusion Performing a 10-cm abdominal wall plication or greater represents a higher risk for intra-abdominal hypertension, slower general recovery, and possibly higher complication rate in patients who presented a lower degree of obesity (grade I) at the moment of the bariatric surgery.

비만환자에서 시행한 슬관절 관절경술 - 증례 보고 - (Knee Arthroscopy in the Obese: A Case Report)

  • 백승훈;김신근
    • 대한관절경학회지
    • /
    • 제14권1호
    • /
    • pp.29-32
    • /
    • 2010
  • 비만환자에서 유용한 수술적 술기와 증가된 술전 및 술후 위험성에 대한 보고들은 있으나, 비만이 관절경적 시술에 미치는 영향에 대한 보고는 거의 없는 실정이다. 저자들은 체중 120kg의 17세 남자환자에서 반월상연골 부분절제술을 시행한 후, 현재까지 출간된 문헌들을 고찰하고 비만환자들에서 슬관절 관절경술 시행시 발생할 수 있는 합병증과 수술적 술기에 대한 정보를 제공하고자 한다.

  • PDF

소아, 청소년 비만 약물 치료의 올바른 이해 (Recommendations of Pharmacological Treatment in Childhood and Adolescents Obesity)

  • 정수진
    • Pediatric Gastroenterology, Hepatology & Nutrition
    • /
    • 제12권sup1호
    • /
    • pp.118-126
    • /
    • 2009
  • The incidence of childhood obesity has increased dramatically. Childhood obesity is an increasing health problem because of its strong associations with chronic health problems in children and adults. These health problems significantly contribute to the development of common chronic diseases in later life, including hypertension, type2 diabetes, hyperinsulinemia, coronary heart disease, and other psychological disorders. So it is an important issue to prevent and treat obesity during childhood and adolescent. Diet and exercise are the cornerstones of treatment for obesity and related complications. For obese children, some clinical trials have shown improvement with diet, exercise, and /or behavioral interventions. Promising interventions for high-risk individuals, such as bariatric surgery and novel pharmacological agents, also require rigorous assessment with attention to long-term patient important outcomes. There are various pharmacological approaches to the treatment of obesity in the adolescent population some of which have FDA approval. In the article we discuss pharmacological approaches to guide the treatment of obesity in the pediatric population, including risks of treatment, monitoring of potential side effects.

Obesity and chronic kidney disease: prevalence, mechanism, and management

  • Yim, Hyung Eun;Yoo, Kee Hwan
    • Clinical and Experimental Pediatrics
    • /
    • 제64권10호
    • /
    • pp.511-518
    • /
    • 2021
  • The prevalence of childhood obesity is increasing worldwide at an alarming rate. While obesity is known to increase a variety of cardiovascular and metabolic diseases, it also acts as a risk factor for the development and progression of chronic kidney disease (CKD). During childhood and adolescence, severe obesity is associated with an increased prevalence and incidence of the early stages of kidney disease. Importantly, children born to obese mothers are also at increased risk of developing obesity and CKD later in life. The potential mechanisms underlying the association between obesity and CKD include hemodynamic factors, metabolic effects, and lipid nephrotoxicity. Weight reduction via increased physical activity, caloric restriction, treatment with angiotensin-converting enzyme inhibitors, and judicious bariatric surgery can be used to control obesity and obesity-related kidney disease. Preventive strategies to halt the obesity epidemic in the healthcare community are needed to reduce the widespread deleterious consequences of obesity including CKD development and progression.

주요우울증을 동반한 고도비만 환자에 대한 행동요법을 병행한 리라글루티드 치료의 2예 (Two Cases of Obesity Treatment Using Liraglutide 3 mg with Intensive Behavioral Changes in Morbidly Obese Patients with Major Depressive Disorder)

  • 고혜진
    • 비만대사연구학술지
    • /
    • 제1권1호
    • /
    • pp.39-42
    • /
    • 2022
  • Obesity is a chronic disease associated with severe complications. A major complication of obesity is depression, which can worsen obesity and vice versa. In addition, most antidepressants or antipsychotics cause weight gain, and the relationship between obesity and depression is clinically critical. However, treatment of obese patients with major depressive disorder is complicated. Bariatric physicians should provide appropriate behavioral interventions alongside pharmacological treatment, considering psychiatric symptoms, drug side effects, and drug interactions. Two successful cases of moderate-to-severe obese patients with major depressive disorder who had been treated for obesity using behavioral intervention therapy along with liraglutide will be discussed. This report highlights the safety and efficacy of liraglutide treatment of obesity in patients with depression who take antidepressants and antipsychotics.

비만환자의 만성콩팥병 관리 (Management of Chronic Kidney Disease in Obesity Patients)

  • 한건희
    • 비만대사연구학술지
    • /
    • 제1권2호
    • /
    • pp.66-73
    • /
    • 2022
  • Obesity is an increasing public health and medical issue worldwide. It has been associated with several comorbidities, including diabetes, cardiovascular disease, stroke, and cancer. Chronic kidney disease (CKD) is another important comorbidity of obesity. Other major causes of CKD include hypertension and diabetes. However, the association between obesity and CKD is often overlooked. Among patients with CKD, patients with obesity were more vulnerable to have rapid kidney function decline than that of those with normal weight. Additionally, CKD is more prevalent among patients with obesity. These aggravations are induced through multiple mechanisms, specifically metabolic impairment of obesity and mechanical burden because of increasing intraabdominal renal pressure. Furthermore, the inflammation and lipotoxicity, caused by obesity, are critical in the CKD aggravation in patients with obesity. To prevent this, all adult patients with obesity are tested for CKD. The workup includes the estimated glomerular filtration rate and regular follow-up. Step-wise management is required for patients with obesity with CKD. Prompt reduction and management of obesity effectively delay CKD progression among patients with obesity and CKD. Therefore, weight loss is a core management for patients with obesity and CKD. Based on several studies, this article focused on the association between CKD and obesity, as well as the diagnosis and weight management of patients with obesity and CKD.

Effects of intragastric balloon on obesity in obese Korean women for 6 months post removal

  • Pak, Hyeon-Ju;Choi, Ha-Neul;Lee, Hong-Chan;Yim, Jung-Eun
    • Nutrition Research and Practice
    • /
    • 제15권4호
    • /
    • pp.456-467
    • /
    • 2021
  • BACKGROUND/OBJECTIVES: The prevalence of morbid obesity in Korean women has consistently been increasing, while the overall prevalence rate of obesity in Korean women seems to be stable. In addition to bariatric surgery, intragastric balloons (IGBs), as a nonsurgical therapy, have been reported to be effective in weight loss. However, the beneficial effects of IGB in Korean women with obesity have not been fully investigated. The aim of this study was to evaluate the changes in fat mass in Korean women with obesity who had undergone IGB treatment for 6 mon. SUBJECTS/METHODS: Seventy-four women with obesity (body mass index [BMI] ≥ 25.0 kg/m2) were recruited. Clinical data, including general information, comorbidities with obesity, anthropometric data, and changes in the body fat composition before and after IGB treatment, were obtained from the subjects. RESULTS: Most subjects had one or more comorbidities, such as osteoarthropathy and woman's disease, and had poor eating behaviors, including irregular mealtimes, eating quickly, and frequent overeating. Body composition measurements showed that weight, fat mass, and waist-hip circumference ratio decreased significantly at 6 mon after IGB treatment. In particular, women with morbid obesity (BMI ≥ 30 kg/m2) showed 33% excess weight loss. There was no significant difference in skeletal muscle mass and mineral contents after IGB treatment. CONCLUSIONS: This study suggested that 6 mon of IGB treatment can be a beneficial treatment for obesity without muscle mass and bone mineral loss.